The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
A groundbreaking treatment for type 2 diabetes has emerged, offering hope to millions of patients worldwide. This innovative ...
New Technique Could Help Treat Aggressive Brain Tumors July 17, 2024 — Burst sine wave electroporation was found to cause less damage to cells and tissue but more disruption to the blood-brain ...
MONDAY, Oct. 14, 2024 (HealthDay News) -- Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need ...
Electroporation works well with cell lines that are refractive to other techniques, such as calcium phosphate–DNA coprecipitation. But as with other transfection methods, the optimal conditions ...
1 This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86 ...
The Gene Pulser Xcell System is a flexible, modular electroporation system for transfecting every cell type from primary, suspension, and difficult-to-transfect cells, including T cells, to bacteria ...
TD Cowen analyst Brendan Smith has maintained their bullish stance on MXCT stock, giving a Buy rating yesterday. Brendan Smith’s rating ...
Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...
November 6, 2024MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.13. Operator: Hello ...
MaxCyte (MXCT) Company Description: MaxCyte Inc operates in the United States healthcare sector. It develops proprietary electroporation technology, which used blood cells instead of traditional ...
More information: Busch, C.B.E, et al. Durable effects of duodenal ablation using electroporation combined with semaglutide to eliminate insulin therapy in patients with type-2 diabetes; the 24 ...